ORMP
Price
$2.29
Change
-$0.02 (-0.86%)
Updated
May 1, 04:44 PM (EDT)
Capitalization
95.18M
27 days until earnings call
VERV
Price
$5.47
Change
-$0.20 (-3.53%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
486.72M
6 days until earnings call
Ad is loading...

ORMP vs VERV

Header iconORMP vs VERV Comparison
Open Charts ORMP vs VERVBanner chart's image
Oramed Pharmaceuticals
Price$2.29
Change-$0.02 (-0.86%)
Volume$100
Capitalization95.18M
Verve Therapeutics
Price$5.47
Change-$0.20 (-3.53%)
Volume$91.98K
Capitalization486.72M
ORMP vs VERV Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VERV commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Buy and VERV is a Buy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (ORMP: $2.32 vs. VERV: $5.64)
Brand notoriety: ORMP and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 78% vs. VERV: 65%
Market capitalization -- ORMP: $95.18M vs. VERV: $486.72M
ORMP [@Biotechnology] is valued at $95.18M. VERV’s [@Biotechnology] market capitalization is $486.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 7 TA indicator(s) are bullish while VERV’s TA Score has 6 bullish TA indicator(s).

  • ORMP’s TA Score: 7 bullish, 3 bearish.
  • VERV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than VERV.

Price Growth

ORMP (@Biotechnology) experienced а +0.43% price change this week, while VERV (@Biotechnology) price change was +3.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was -7.74%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($487M) has a higher market cap than ORMP($95.2M). VERV YTD gains are higher at: 0.089 vs. ORMP (-4.132). ORMP has higher annual earnings (EBITDA): 9.44M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. ORMP (142M). ORMP has less debt than VERV: ORMP (429K) vs VERV (70M). VERV has higher revenues than ORMP: VERV (32.3M) vs ORMP (0).
ORMPVERVORMP / VERV
Capitalization95.2M487M20%
EBITDA9.44M-221.91M-4%
Gain YTD-4.1320.089-4,661%
P/E Ratio20.91N/A-
Revenue032.3M-
Total Cash142M524M27%
Total Debt429K70M1%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVERV
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFIDX87.75N/A
N/A
Fidelity
IASRX21.13N/A
N/A
Macquarie Asset Strategy Fund Cl R
TPIAX13.44N/A
N/A
Timothy Plan International A
LKBLX51.19N/A
N/A
LK Balanced Institutional
FOSCX26.49-0.14
-0.53%
Tributary Small Company Instl

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+3.39%
BEAM - VERV
57%
Loosely correlated
+1.01%
CRSP - VERV
54%
Loosely correlated
+3.40%
ARWR - VERV
50%
Loosely correlated
+2.97%
RXRX - VERV
50%
Loosely correlated
-2.27%
PRME - VERV
50%
Loosely correlated
+8.13%
More